180 related articles for article (PubMed ID: 738119)
1. Disopyramide in patients with the Wolff-Parkinson-White syndrome and atrial fibrillation.
Bennett DH
Chest; 1978 Dec; 74(6):624-8. PubMed ID: 738119
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic effects of disopyramide phosphate in patients with Wolff-Parkinson-White syndrome.
Kerr CR; Prystowsky EN; Smith WM; Cook L; Gallagher JJ
Circulation; 1982 May; 65(5):869-78. PubMed ID: 6804107
[TBL] [Abstract][Full Text] [Related]
3. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
[TBL] [Abstract][Full Text] [Related]
4. The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.
Deano DA; Wu D; Mautner RK; Sherman RH; Ehsani AI; Rosen KM
Chest; 1977 May; 71(5):597-606. PubMed ID: 856558
[TBL] [Abstract][Full Text] [Related]
5. Acute effect of disopyramide on atrial fibrillation in the Wolff-Parkinson-White syndrome.
Fujimura O; Klein GJ; Sharma AD; Yee R; Szabo T
J Am Coll Cardiol; 1989 Apr; 13(5):1133-7. PubMed ID: 2926064
[TBL] [Abstract][Full Text] [Related]
6. Treatment of arrhythmias in the Wolff-Parkinson-White syndrome.
Forester D
Chest; 1979 Jun; 75(6):745. PubMed ID: 436537
[No Abstract] [Full Text] [Related]
7. The effect of intravenous disopyramide phosphate on recurrent paroxysmal tachycardias.
Camm J; Ward D; Spurrell RA
Br J Clin Pharmacol; 1979 Nov; 8(5):441-9. PubMed ID: 508548
[TBL] [Abstract][Full Text] [Related]
8. [Electrophysiological action of disopyramide].
Grosu AA; Malakhov VI; Smetnev AS
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):51-5. PubMed ID: 7138657
[TBL] [Abstract][Full Text] [Related]
9. Clinical studies of Norpace (Part X).
Dreifus LS
Angiology; 1975 Jan; 26(1 Pt 2):148. PubMed ID: 46728
[No Abstract] [Full Text] [Related]
10. Effects of a combination of disopyramide and mexiletine on the anterograde accessory pathway conduction in patients with Wolff-Parkinson-White syndrome.
Shimizu W; Ohe T; Kurita T; Takaki H; Aihara N; Kamakura S; Matsuhisa M; Shimomura K
Eur Heart J; 1992 Feb; 13(2):261-8. PubMed ID: 1555626
[TBL] [Abstract][Full Text] [Related]
11. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
Gulamhusein S; Ko P; Carruthers SG; Klein GJ
Circulation; 1982 Feb; 65(2):348-54. PubMed ID: 7053894
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravenous disopyramide in the termination of supraventricular arrhythmias.
Luoma PV; Kujala PA; Juustila HJ; Takkunen JT
J Clin Pharmacol; 1978; 18(5-6):293-301. PubMed ID: 641217
[No Abstract] [Full Text] [Related]
13. Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
Bauernfeind RA; Swiryn SP; Strasberg B; Palileo E; Scagliotti D; Rosen KM
Am Heart J; 1982 Jun; 103(6):941-9. PubMed ID: 7081034
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic and clinical effects of intravenous and oral encainide in patients with Wolff-Parkinson-White syndrome and paroxysmal atrial fibrillation.
Chimienti M; Moizi M; Salerno JA; Klersy C; Guasti L; Previtali M; Marangoni E; Montemartini C; Bobba P
Eur Heart J; 1987 Mar; 8(3):282-90. PubMed ID: 3107987
[TBL] [Abstract][Full Text] [Related]
15. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
[TBL] [Abstract][Full Text] [Related]
16. Magnesium reversal of digoxin-facilitated ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
Merrill JJ; DeWeese G; Wharton JM
Am J Med; 1994 Jul; 97(1):25-8. PubMed ID: 8030653
[TBL] [Abstract][Full Text] [Related]
17. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
Morady F; DiCarlo LA; Baerman JM; De Buitleir M
Pacing Clin Electrophysiol; 1987 May; 10(3 Pt 1):492-6. PubMed ID: 2439997
[TBL] [Abstract][Full Text] [Related]
18. Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome.
McGovern B; Garan H; Ruskin JN
Ann Intern Med; 1986 Jun; 104(6):791-4. PubMed ID: 3706931
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of isoproterenol during atrial fibrillation in evaluation of asymptomatic Wolff-Parkinson-White pattern.
Szabo TS; Klein GJ; Sharma AD; Yee R; Milstein S
Am J Cardiol; 1989 Jan; 63(3):187-92. PubMed ID: 2909998
[TBL] [Abstract][Full Text] [Related]
20. Flecainide in the Wolff-Parkinson-White syndrome.
Crozier I
Am J Cardiol; 1992 Aug; 70(5):26A-32A. PubMed ID: 1509995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
